| 前收盘价格 | 14.00 |
| 收盘价格 | 13.91 |
| 成交量 | 661,775 |
| 平均成交量 (3个月) | 693,209 |
| 市值 | 1,812,154,112 |
| 价格/销量 (P/S) | 3.22 |
| 股市价格/股市净资产 (P/B) | 2.32 |
| 52周波幅 | |
| 利润日期 | 5 Nov 2024 |
| 营业毛利率 | -12.07% |
| 营业利益率 (TTM) | -8.39% |
| 稀释每股收益 (EPS TTM) | -0.610 |
| 季度收入增长率 (YOY) | 10.40% |
| 总债务/股东权益 (D/E MRQ) | 66.75% |
| 流动比率 (MRQ) | 1.99 |
| 营业现金流 (OCF TTM) | 15.01 M |
| 杠杆自由现金流 (LFCF TTM) | 9.09 M |
| 资产报酬率 (ROA TTM) | -2.76% |
| 股东权益报酬率 (ROE TTM) | -8.38% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 混合的 | 混合的 |
| Diagnostics & Research (全球的) | 混合的 | 混合的 | |
| 股票 | NeoGenomics, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 4.0 |
| 内部交易活动 | -1.5 |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.50 |
|
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Small Growth |
| 内部持股比例 | 1.21% |
| 机构持股比例 | 99.79% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 22.00 (Jefferies, 55.59%) | 购买 |
| 中 | 19.00 (34.37%) | |
| 低 | 18.00 (Benchmark, 27.30%) | 购买 |
| 平均值 | 19.50 (37.91%) | |
| 总计 | 3 购买, 1 保留 | |
| 平均价格@调整类型 | 16.86 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| B of A Securities | 13 Dec 2024 | 19.00 (34.37%) | 保留 | 17.73 |
| Jefferies | 10 Dec 2024 | 22.00 (55.59%) | 购买 | 18.43 |
| Needham | 06 Nov 2024 | 19.00 (34.37%) | 购买 | 15.46 |
| 25 Sep 2024 | 19.00 (34.37%) | 购买 | 14.96 | |
| Benchmark | 24 Sep 2024 | 18.00 (27.30%) | 购买 | 15.80 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合